September 1, 2017 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Bristol-Myers Squibb and QIAGEN Sign Agreement for Use of NGS Technology to Develop Gene Expression Profiles for Immuno-Oncology Therapies

NEW YORK and HILDEN, Germany, (June 3, 2017) – Bristol-Myers Squibb Company (NYSE: BMY) and QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) have signed an agreement to explore the use of next-generation sequencing (NGS) technology to develop gene expression profiles (GEPs) as predictive or prognostic tools for use with Bristol-Myers Squibb novel immuno-oncology (I-O) therapies... Read more

August 31, 2017 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Seegene accelerates ‘Project 100’ by securing 30 co-development partners

2017.08.31 Seoul, Korea, 2017/08/31 – Seegene, the world’s leading developer of multiplex molecular technologies and assays, announced that it has recently signed collaborative contracts with 30 general hospitals and reference laboratories across 15 nations for the co-development of ‘Project 100’ products. Contracting parties are mostly the largest commercial labs in the country, university hospitals, and... Read more

August 31, 2017 Clinical Research/Diagn. PR/Corporate Product Launch

Roche to present new data from its oncology portfolio at the 2017 European Society for Medical Oncology (ESMO) Congress

Basel, 31 August 2017 Roche to present new data from its oncology portfolio at the 2017 European Society for Medical Oncology (ESMO) Congress Data from 18 approved and investigational cancer medicines to be presented at ESMO 2017 Results for Zelboraf (vemurafenib) as an adjuvant treatment for BRAF V600 mutation-positive melanoma to feature in the ESMO... Read more

August 28, 2017 Chromatography Clinical Research/Diagn. Lab Top-10 Product Launch

Phenomenex Publishes Second Edition of Comprehensive Clinical Application Notebook

Torrance, Calif. (August 28, 2017) – Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announces the publication of a new clinical application guide. This 136-page digital notebook is the second edition of the guide and presents 36 updated or entirely new applications developed by PhenoLogix™, Phenomenex’s... Read more

August 15, 2017 Clinical Research/Diagn. Informatics & Software M&A, Partnerships

Seven Bridges Selected To Build Groundbreaking Data Analysis Platform To Fight Pediatric Disease

August 15, 2017 New data resource center will be created with the NIH and Children’s Hospital of Philadelphia to enable pediatric research across both cancer and structural birth defects datasets for the first time BOSTON, Mass., and PHILADELPHIA, Penn., August 15, 2017 –  Seven Bridges, the biomedical data analysis company, today announced that it has been selected... Read more

August 10, 2017 Clinical Research/Diagn. Lab Top-10

Beckman Coulter Diagnostics Announces Enhancements to the Access 2 Immunoassay System

Built upon a 20 year legacy of reliable and efficient performance, the Access 2 delivers new features that advance end-user experience and productivity. BREA, Calif., Aug. 10, 2017 /PRNewswire/ — Beckman Coulter Diagnostics is pleased to announce worldwide availability of the Access 2 immunoassay system with enhanced features. Built upon a 20-year legacy of reliable and efficient performance, the Access... Read more

August 4, 2017 Clinical Research/Diagn. Lab Top-10

FDA Issues Emergency Use Authorization for Thermo Fisher Scientific’s Zika Virus Assay

CARLSBAD, Calif., Aug. 3, 2017 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization for the company’s new TaqPath Zika Virus Kit. The TaqPath Zika Virus Kit is authorized only for the qualitative detection of RNA from Zika virus and... Read more

August 3, 2017 Clinical Research/Diagn. Lab Top-10 Life Science Tools Product Launch

PerkinElmer Launches Clinical Whole Genome Sequencing Services

PerkinElmer Genetics Provides Complete Genomic Lab Testing Solution WALTHAM, Mass.–(BUSINESS WIRE)– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced the launch of PerkinElmer Genetics’ clinical genomics services. Through its integrated laboratories in the U.S., India and China, PerkinElmer offers a global genomic lab testing platform that performs... Read more

August 1, 2017 Cell Analysis Tools Clinical Research/Diagn. Lab Top-10 PR/Corporate

Beckman Coulter Highlights the First US IVD Test Delivering Flow Cytometric Leukemia & Lymphoma* Analysis in the Routine Clinical Lab

Clinical Flow Cytometry Innovation Highlighted on Booth #3117, AACC 2017 SAN DIEGO, CALIF. ─ (July 31, 2017) ─ Beckman Coulter Life Sciences features its pioneering in vitro diagnostic ClearLLab reagents at the 69th American Association for Clinical Chemistry (AACC) Annual Scientific Meeting and Clinical Laboratory Expo (CLE), being held July 31 – August 3, 2017 in... Read more